To study the clinical relevance of LAMP2a and RNH1, we detected the expression of LAMP2a, RNH1, and mTOR in a tissue microarray containing 94 CRC tumor and 88 normal tissue samples, by means of multiplex immunohistochemistry staining. This evidence concerns the gene MTOR and colorectal carcinoma.